Rotenone Model of Parkinson Disease
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Chronic infusion of rotenone (Rot) to Lewis rats reproduces many features of Parkinson disease. Rot (3 mg/kg/day) was infused subcutaneously to male Lewis rats for 6 days using Alzet minipumps. Control rats received the vehicle only. Presence of 0.1% bovine serum albumin during the isolation procedure completely removed rotenone bound to the mitochondria. Therefore all functional changes observed were aftereffects of rotenone toxicity in vivo. In Rot rat brain mitochondria (Rot-RBM) there was a 30-40% inhibition of respiration in State 3 and State 3U with Complex I (Co-I) substrates and succinate. Rot did not affect the State 4Deltapsi of RBM and rat liver mitochondria (RLM). However, Rot-RBM required two times less Ca2+ to initiate permeability transition (mPT). There was a 2-fold increase in O*2- or H2O2 generation in Rot-RBM oxidizing glutamate. Rot infusion affected RLM little. Our results show that in RBM, the major site of reactive oxygen species generation with glutamate or succinate is Co-I. We also found that Co-II generates substantial amounts of reactive oxygen species that increased 2-fold in the Rot-RBM. Our data suggest that the primary mechanism of the Rot toxic effect on RBM consists in a significant increase of O*2- generation that causes damage to Co-I and Co-II, presumably at the level of 4Fe-4S clusters. Decreased respiratory activity diminishes resistance of RBM to Ca2+ and thus increases probability of mPT and apoptotic cell death. We suggest that the damage to Co-I and Co-II shifts O*2- generation from the CoQ10 sites to more proximal sites, such as flavines, and makes it independent of the RBM functional state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blockade of rotenone to the binding site of ubiquinone leads to reduced electron flow to complex III and reverse electron flow through complex I into the mitochondrial matrix leading to increased ROS generation in this compartment, namely matrix mtROS [269,416,419,420,421].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [420]
In the citing paper
“ROS can damage TCA-cycle enzymes, especially aconitase and α-ketoglutarate dehydrogenase (62, 168, 249, 250, 277).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [250]
In the citing paper
“Succinate dehydrogenase (complex II) is very resistant to oxidation by H2O2 or tert-butyl hydroperoxide (tert-BuOOH) (250), but α-ketoglutarate dehydrogenase activity is markedly decreased (168, 250) because of its susceptibility for modification by peroxides of its thiol groups (167, 249).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [250]
Citations
Cites
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationSuperoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Self-citationNeurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Self-citationCadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855
Activation of molecular oxygen by flavins and flavoproteins.
Massey, V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31664-2 · Cited by 816
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Self-citation
Research works printed but not linked: 2
- Cluskey, 2001, Mol. Pathol., 54, 386
- Sherer, 2003, Ann. Neurol., 341, 87
Cited by
Ageing and neuronal vulnerability
Mattson, M. P., & Magnus, T. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1886 · Cited by 957
“For example, exposure of humans, monkeys and/or rodents to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) or rotenone causes PD-like pathology and symptoms, whereas exposure to 3-nitropropionic acid can cause HD-like damage to striatal neuron”
BackgroundMitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 841
Nox proteins in signal transduction
Brown, D. I., & Griendling, K. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.023 · Cited by 832
Cross talk between mitochondria and NADPH oxidases
Dikalov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.033 · Cited by 783
Self-citationKeeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
Self-citationFunctions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Methods for Detection of Mitochondrial and Cellular Reactive Oxygen Species
Dikalov, S. I., & Harrison, D. G. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4886 · Cited by 630
Self-citationStowe, D. F., & Camara, A. K. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2331 · Cited by 471
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
Morais, V. A., Verstreken, P., Roethig, A., Smet, J., Snellinx, A., Vanbrabant, M., Haddad, D., Frezza, C., Mandemakers, W., Vogt‐Weisenhorn, D., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900006 · Cited by 434
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Flint Beal, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 413
“rat brain [14].”
Janssen, A. J., Trijbels, F. J., Sengers, R. C., Smeitink, J. A., van den Heuvel, L. P., Wintjes, L. T., Stoltenborg-Hogenkamp, B. J., & Rodenburg, R. J. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078873 · Cited by 373
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Sanders, L. H., & Timothy Greenamyre, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 345
Self-citationPhospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal
Sun, W.-Y., Tyurin, V. A., Mikulska-Ruminska, K., Shrivastava, I. H., Anthonymuthu, T. S., Zhai, Y.-J., Pan, M.-H., Gong, H.-B., Lu, D.-H., Sun, J., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00734-x · Cited by 337
Dikalov, S. I., Nazarewicz, R. R., Bikineyeva, A., Hilenski, L., Lassègue, B., Griendling, K. K., Harrison, D. G., & Dikalova, A. E. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4918 · Cited by 310
Self-citationInterplay between oxidant species and energy metabolism
Quijano, C., Trujillo, M., Castro, L., & Trostchansky, A. (2016) · Redox Biology · doi:10.1016/j.redox.2015.11.010 · Cited by 304
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 292
Mitochondria: A therapeutic target in neurodegeneration
Moreira, P. I., Zhu, X., Wang, X., Lee, H.-G., Nunomura, A., Petersen, R. B., Perry, G., & Smith, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 285
Vos, M. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00139 · Cited by 280
“…in Parkinson’s disease (PD) came from the observation that mitochondrial drugs like MPTP and rotenone that specifically affect complex I of the ETC (Figure 1) cause PD-like symptoms, including degeneration of dopaminergic neurons (German et al., 1989; Betarbet et al., 2000; Panov et al., 2005).”
Lenaz, G., & Genova, M. L. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2704 · Cited by 260
Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15314 · Cited by 237
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
Armstrong, J. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707288 · Cited by 234
Fatty Acids in Energy Metabolism of the Central Nervous System
Panov, A., Orynbayeva, Z., Vavilin, V., & Lyakhovich, V. (2014) · BioMed Research International · doi:10.1155/2014/472459 · Cited by 227
Self-citationMitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence
Morais, V. A., & De Strooper, B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100345 · Cited by 111
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D., Hunter, R. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 222
Radad, K., Rausch, W.-D., & Gille, G. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.02.003 · Cited by 220
“It was reported by several groups that complex I inhibition by rotenone may result in opening of the mitochondrial permeability transition pore (PTP) and massive production of ROS (Seaton et al., 1997; Hensley et al., 1998; Zorov et al., 2000; Isenberg and Klaunig, 2000; Pei et al., 2003; Panov et al., 2005).”
BackgroundRole of mitochondrial oxidative stress in hypertension
Dikalov, S. I., & Ungvari, Z. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00089.2013 · Cited by 201
Self-citationMastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195
Self-citationPhotooxidation of Amplex red to resorufin: Implications of exposing the Amplex red assay to light
Zhao, B., Summers, F. A., & Mason, R. P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.034 · Cited by 194
Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model
Ghosh, A., Chandran, K., Kalivendi, S. V., Joseph, J., Antholine, W. E., Hillard, C. J., Kanthasamy, A., Kanthasamy, A., & Kalyanaraman, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.028 · Cited by 190
Tamilselvam, K., Braidy, N., Manivasagam, T., Essa, M. M., Prasad, N. R., Karthikeyan, S., Thenmozhi, A. J., Selvaraju, S., & Guillemin, G. J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/102741 · Cited by 182
Disruption of mitochondrial redox circuitry in oxidative stress
Jones, D. P. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.07.008 · Cited by 176
Hosamani, R., & ., M. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.08.012 · Cited by 173
“…various rat strains, making it difficult to test new pharmacological treatments for PD. Previously, many workers have attempted to attenuate rotenone induced oxidative stress and neurotoxic effects using various therapeutic agents both in vitro and in vivo mammalian model (Panov et al., 2005).”
BackgroundMitochondrial Redox Cycling of Mitoquinone Leads to Superoxide Production and Cellular Apoptosis
Doughan, A. K., & Dikalov, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1693 · Cited by 172
Self-citationEPR detection of cellular and mitochondrial superoxide using cyclic hydroxylamines
Dikalov, S. I., Kirilyuk, I. A., Voinov, M., & Grigor'ev, I. A. (2011) · Free Radical Research · doi:10.3109/10715762.2010.540242 · Cited by 171
“Mitochondrial O 2 • – production was studied in the presence of 2 mM malate 20 mM glutamate and 20 μ g of mitochondrial protein [29].”
BackgroundMethodSelf-citationPower, J. H. T., & Blumbergs, P. C. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0438-3 · Cited by 171
“Environmental toxins such as rotenone generate oxidative stress via mitochondrial dysfunction [ 19 ] probably leading to oxidation of native -synuclein and other proteins resulting in protein aggregation and Lewy body formation.”
BackgroundAIF, reactive oxygen species, and neurodegeneration: A “complex” problem
Polster, B. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.002 · Cited by 168
Chu, C. T., Zhu, J., & Dagda, R. K. (2007) · Autophagy · doi:10.4161/auto.4625 · Cited by 153
“Additionally, class II PI3Ks that are resistant to wortmannin can produce both PI(3)P and PI(3,4)P2.”
BackgroundThe mitochondrial free radical theory of ageing - Where do we stand?
Gruber, J. (2008) · Frontiers in Bioscience · doi:10.2741/3174 · Cited by 167
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
Ibarra-Gutiérrez, M. T., Serrano-García, N., & Orozco-Ibarra, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03193-8 · Cited by 165
Myhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 152
Masuo, Y., & Ishido, M. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.578557 · Cited by 136
Ozone Therapy: Clinical and Basic Evidence of Its Therapeutic Potential
Re, L., Mawsouf, M. N., Menéndez, S., León, O. S., Sánchez, G. M., & Hernández, F. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.07.005 · Cited by 159
Shaltouki, A., Sivapatham, R., Pei, Y., Gerencser, A. A., Momčilović, O., Rao, M. S., & Zeng, X. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.019 · Cited by 130
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 143
Panov, A., Dikalov, S., Shalbuyeva, N., Hemendinger, R., Greenamyre, J. T., & Rosenfeld, J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00202.2006 · Cited by 141
“Besides, recent experiments have shown that during systemic intoxication with rotenone, the brain mitochondria were severely damaged, whereas liver mitochondria remained virtually unaffected (40).”
BackgroundMethodInfluentialSelf-citationNagatsu, T., & Sawada, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9061-9 · Cited by 141
“It was reported that the primary mechanism underlying the toxic effect of rotenone was a significant increase in O2− generation that causes damage to mitochondrial complexes I and II, presumably at the level of the 4Fe–4S clusters (Panov et al., 2005).”
BackgroundEschbach, J., von Einem, B., Müller, K., Bayer, H., Scheffold, A., Morrison, B. E., Rudolph, K. L., Thal, D. R., Witting, A., Weydt, P., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24294 · Cited by 125
The H+-ATP synthase: A gate to ROS-mediated cell death or cell survival
Martínez‐Reyes, I., & Cuezva, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.03.010 · Cited by 136
Abdelkader, N. F., Safar, M. M., & Salem, H. A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9043-8 · Cited by 127
Badawi, G. A., Fattah, M. A. A. E., Zaki, H. F., & Sayed, M. I. E. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0331-6 · Cited by 127
mTOR Signaling in Parkinson’s Disease
Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 126
The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants
Vilain, S., Esposito, G., Haddad, D., Schaap, O., Dobreva, M. P., Vos, M., Van Meensel, S., Morais, V. A., De Strooper, B., & Verstreken, P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002456 · Cited by 110
Giampieri, F., Álvarez-Suárez, J. M., Cordero, M. D., Gasparrini, M., Forbes-Hernández, T. Y., Afrin, S., Santos‐Buelga, C., Gonzaléz‐Paramás, A. M., Astolfi, P., Rubini, C., et al. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.05.017 · Cited by 122
Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors
Kim, D. Y., Vallejo, J., & Rho, J. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06728.x · Cited by 113
Revisiting the Paraquat-Induced Sporadic Parkinson’s Disease-Like Model
Candia, S. B., Zolezzi, J. M., & Inestrosa, N. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1148-z · Cited by 115
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation
Ho, G.-T., Aird, R. E., Liu, B., Boyapati, R. K., Kennedy, N. A., Dorward, D. A., Noble, C. L., Shimizu, T., Carter, R. N., Chew, E. T. S., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.31 · Cited by 110
Phosphine toxicity: a story of disrupted mitochondrial metabolism
Sciuto, A. M., Wong, B. J., Martens, M. E., Hoard-Fruchey, H. M., & Perkins, M. W. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13081 · Cited by 112
Neurological disorders and mitochondria
Cabral‐Costa, J. V., & Kowaltowski, A. J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.003 · Cited by 112
Mariappan, N., Elks, C. M., Fink, B., & Francis, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.049 · Cited by 103
Miwa, S., Treumann, A., Bell, A., Vistoli, G., Nelson, G., Hay, S., & von Zglinicki, T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.011 · Cited by 107
Park, S., Sapkota, K., Choi, J., Kim, M.-K., Kim, Y. H., Kim, K. M., Kim, K. J., Oh, H.-N., Kim, S.-J., & Kim, S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1259-5 · Cited by 102
Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress
Nazarewicz, R. R., Dikalova, A. E., Bikineyeva, A., & Dikalov, S. I. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00063.2013 · Cited by 99
Self-citationReactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 87
Liu, J., Copland, D. A., Theodoropoulou, S., Chiu, H. A. A., Barba, M. D., Mak, K. W., Mack, M., Nicholson, L. B., & Dick, A. D. (2016) · Scientific Reports · doi:10.1038/srep20639 · Cited by 100
Approaches for Reactive Oxygen Species and Oxidative Stress Quantification in Epilepsy
Taiwo, R. O., Sandouka, S., Saadi, A., & Shekh‐Ahmad, T. (2020) · Antioxidants · doi:10.3390/antiox9100990 · Cited by 99
“Second to the DCF is the N-acetyl-3,7-dihydroxyphenoxazine (Amplex Red), which can be used to selectively detect H2O2 released from isolated mitochondria [86], it is oxidized by H2O2 in the presence of horseradish peroxidase (HRP) and then converted to resorufin [75].”
MethodSánchez-Reus, M. I., del Río, M. A. G., Peinado, I. I., Elorza, M., Slowing, K., & Benedí, J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.003 · Cited by 99
Paul, R., Choudhury, A., Kumar, S., Giri, A., Sandhir, R., & Borah, A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171285 · Cited by 91
Feng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96
DJ-1 knock-down impairs astrocyte mitochondrial function
Larsen, N. J., Ambrosi, G., Mullett, S. J., Berman, S. B., & Hinkle, D. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.016 · Cited by 82
“This finding may be relevant to PD because pharmacologic inhibition of Complex I using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or pesticides (rotenone) causes mitochondrial dysfunction and experimental parkinsonism (Langston et al., 1984; Ballard et al., 1985; Betarbet et al., 2000; Panov et al., 2005; Can…”
BackgroundSriram, K., Lin, G. X., Jefferson, A. M., Roberts, J. R., Wirth, O., Hayashi, Y., Krajnak, K., Soukup, J. M., Ghio, A. J., Reynolds, S. H., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-163964 · Cited by 94
Tyurina, Y. Y., Polimova, A. M., Maciel, E., Tyurin, V. A., Kapralova, V. I., Winnica, D. E., Vikulina, A. S., Domingues, M. R. M., McCoy, J., Sanders, L. H., et al. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1005085 · Cited by 81
Self-citationOxidative stress and Parkinson's disease
Jenner, P. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83024-7 · Cited by 89
Pandey, M., Varghese, M., Madathil, S. K., Sreetama, S. C., Kaidery, N. A., Mohanakumar, K. P., & Rajamma, U. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04996.x · Cited by 89
Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration
Fato, R., Bergamini, C., Leoni, S., Strocchi, P., & Lenaz, G. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9747-0 · Cited by 87
Thymoquinone exerts neuroprotective effect in animal model of Parkinson’s disease
Ebrahimi, S. S., Oryan, S., Izadpanah, E., & Hassanzadeh, K. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.05.018 · Cited by 87
Zhou, P., Qian, L., D’Aurelio, M., Cho, S., Wang, G., Manfredi, G., Pickel, V. M., & Iadecola, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2849-11.2012 · Cited by 86
Mullett, S. J., & Hinkle, D. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07175.x · Cited by 77
Li, X.-X., He, G., Mu, X. L., Xu, B., Tian, S., Yu, X., Meng, F.-R., Xuan, Z.-H., & Du, G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.181 · Cited by 85
Rahimmi, A., Khosrobakhsh, F., Izadpanah, E., Moloudi, M. R., & Hassanzadeh, K. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.02.007 · Cited by 85
DNA damage and repair in Parkinson's disease: Recent advances and new opportunities
González-Hunt, C. P., & Sanders, L. H. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24592 · Cited by 84
“Although there has been an emphasis on investigating various facets of mitochondrial function, including bioenergetic defects in PD (Keeney, Xie, Capaldi, & Bennett, 2006; Panov et al., 2005), there is strong evidence for the disruption of mitochondrial genome maintenance.”
BackgroundAhmadian, E., Pennefather, P., Eftekhari, A., Heidari, R., & Eghbal, M. A. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1207523 · Cited by 82
“4Hydroxynonenal (4-HNE) is a reactive aldehydic product of lipid peroxidation induced by oxidative stress, which in turn interferes with mitochondrial respiratory chain [109,110].”
BackgroundLawal, H. O., Chang, H.-Y., Terrell, A. N., Brooks, E. S., Pulido, D., Simon, A. F., & Krantz, D. E. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.008 · Cited by 82
Photooxidation of Amplex Red to Resorufin
Summers, F. A., Zhao, B., Ganini, D., & Mason, R. P. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-405883-5.00001-6 · Cited by 82
Duty, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00882.x · Cited by 77
Horowitz, M. P., Milanese, C., Di Maio, R., Hu, X., Montero, L. M., Sanders, L. H., Tapias, V., Sepe, S., van Cappellen, W. A., Burton, E. A., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3629 · Cited by 75
Self-citationDikalov, S. I., Li, W., Doughan, A. K., Blanco, R. R., & Zafari, A. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00842.2010 · Cited by 73
Self-citationKoju, N., Taleb, A., Zhou, J., Ge, L., Yang, J., Cao, X., Lei, H., & Ding, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.128 · Cited by 75
Pienaar, I. S., Elson, J. L., Racca, C., Nelson, G., Turnbull, D. M., & Morris, C. M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.002 · Cited by 74
Naoi, M., Maruyama, W., Yi, H., Inaba, K., Akao, Y., & Shamoto‐Nagai, M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0309-7 · Cited by 74
“... of PD. The results on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrine (MPTP) (Langston et al. 1983) indicate that mitochondria and type B monoamine oxidase (MAO-B), localized at their outer membrane, are involved in the pathogenesis of PD. The defect of complex I was detected in the SN of PD bra…”
BackgroundArif, I. A., & Khan, H. A. (2010) · Toxicology and Industrial Health · doi:10.1177/0748233710362382 · Cited by 74
DJ-1 Expression Modulates Astrocyte-Mediated Protection Against Neuronal Oxidative Stress
Mullett, S. J., Di Maio, R., Greenamyre, J. T., & Hinkle, D. A. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9904-4 · Cited by 68
“Rotenone causes oxidative stress and experimental parkinsonism (Betarbet et al. 2000; Cannon et al. 2009; Panov et al. 2005).”
Self-citationPaul, R. K., Phukan, B. C., Thenmozhi, A. J., Manivasagam, T., Bhattacharya, P., & Borah, A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.016 · Cited by 73
Watabe, M., & Nakaki, T. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127597 · Cited by 71
Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria
Chinta, S. J., Rane, A., Yadava, N., Andersen, J. K., Nicholls, D. G., & Polster, B. M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.010 · Cited by 62
PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1
Corona, J. C., de Souza, S. C., & Duchen, M. R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.012 · Cited by 69
Wei, Y., Clark, S. E., Thyfault, J. P., Uptergrove, G. M., Li, W., Whaley‐Connell, A. T., Ferrario, C. M., Sowers, J. R., & Ibdah, J. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080697 · Cited by 69
Cardiolipin Signaling Mechanisms: Collapse of Asymmetry and Oxidation
Kagan, V. E., Tyurina, Y. Y., Tyurin, V. A., Mohammadyani, D., Angeli, J. P. F., Baranov, S. V., Klein-Seetharaman, J., Friedlander, R. M., Mallampalli, R. K., Conrad, M., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6219 · Cited by 65
Barreca, D., Currò, M., Bellocco, E., Ficarra, S., Laganà, G., Tellone, E., Giunta, M. L., Visalli, G., Caccamo, D., Galtieri, A., et al. (2017) · BioFactors · doi:10.1002/biof.1358 · Cited by 69
Metadata
- Authors
- Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., & Greenamyre, J. T.
- Affiliations
- Carolinas Healthcare System (US)
- Emory University (US)
- Corresponding author
- Panov, Alexander
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 51
- Pages
- 42026-42035
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1996971085
- Cited by
- 288
- References
- 54
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 11 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 8 · 2014: 19 · 2013: 24 · 2012: 15
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5419 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES012068, U54ES012068)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- rotenone, Parkinson's disease, mitochondrial complex I, complex II, reactive oxygen species, superoxide production, mitochondrial permeability transition, mitochondrial respiration, glutamate oxidation, succinate oxidation, [4Fe-4S] cluster, apoptosis, Lewis rats
- MeSH terms
- Animals, Brain, Disease Models, Animal, Male, Mitochondria, Parkinson Disease, Rats, Inbred Lew, Rotenone, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.